FDA Issues Warning on Common Diabetes Drugs

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The FDA warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca, Johnson & Johnson and Eli Lilly in partnership with Boehringer Ingleheim may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. Via Newsmax Health. Posted May 16, 2015.

–Alanna McCatty


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

The Vitamins and Minerals to Boost Your Immune System

The Vitamins and Minerals to Boost Your Immune System

As we re-enter the world after months of self-isolating, is there going to be another spike in COVID-19 infections? Perhaps. However, as you increase your contact with more people, having a strong immune system is a key part of keeping healthy. To boost your immune system, make sure you are getting…

  • Advertisement